TY - JOUR
T1 - A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer
JO - British Journal of Cancer
PY - 2004/08/01
AU - Hussain SA
AU - Stocken DD
AU - Riley P
AU - Palmer DH
AU - Peake DR
AU - Geh JI
AU - Spooner D
AU - James ND
ED -
DO - DOI: 10.1038/sj.bjc.6602112
PB - Springer Science and Business Media LLC
VL - 91
IS - 5
SP - 844
EP - 849
Y2 - 2025/07/12
ER -